טוען...
Engineering effective T-cell based antitumor immunity
The adoptive transfer of synthetic siRNA-mediated cblb-depleted autologous CD8(+) T cells acts as a potent adjuvant for dendritic cell (DC) vaccination and provides a significant therapeutic benefit. Our proof-of-concept study validates the strategy of inhibiting CBLB as a rational approach to augme...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Landes Bioscience
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601162/ https://ncbi.nlm.nih.gov/pubmed/23525844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22893 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|